These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 20530654

  • 1. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
    Gbahou F, Davenas E, Morisset S, Arrang JM.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):945-54. PubMed ID: 20530654
    [Abstract] [Full Text] [Related]

  • 2. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang JM.
    Br J Pharmacol; 2006 Apr 01; 147(7):744-54. PubMed ID: 16432504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
    Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC, Ganellin CR.
    J Pharmacol Exp Ther; 1992 Oct 01; 263(1):304-10. PubMed ID: 1383495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
    Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J.
    J Pharmacol Exp Ther; 1998 Nov 01; 287(2):658-66. PubMed ID: 9808693
    [Abstract] [Full Text] [Related]

  • 8. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA.
    J Pharmacol Exp Ther; 2005 Jul 01; 314(1):271-81. PubMed ID: 15821027
    [Abstract] [Full Text] [Related]

  • 9. Constitutive activity of the histamine H3 receptor.
    Arrang JM, Morisset S, Gbahou F.
    Trends Pharmacol Sci; 2007 Jul 01; 28(7):350-7. PubMed ID: 17573125
    [Abstract] [Full Text] [Related]

  • 10. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR, Baranowski JL, Estvander BR, Witte DG, Carr TL, Manelli AM, Krueger KM, Cowart MD, Brioni JD, Esbenshade TA.
    Assay Drug Dev Technol; 2008 Jun 01; 6(3):339-49. PubMed ID: 18593375
    [Abstract] [Full Text] [Related]

  • 11. A new family of H3 receptor antagonists based on the natural product Conessine.
    Santora VJ, Covel JA, Hayashi R, Hofilena BJ, Ibarra JB, Pulley MD, Weinhouse MI, Sengupta D, Duffield JJ, Semple G, Webb RR, Sage C, Ren A, Pereira G, Knudsen J, Edwards JE, Suarez M, Frazer J, Thomsen W, Hauser E, Whelan K, Grottick AJ.
    Bioorg Med Chem Lett; 2008 Feb 15; 18(4):1490-4. PubMed ID: 18194865
    [Abstract] [Full Text] [Related]

  • 12. Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptors.
    Sors A, Panayi F, Bert L, Favale D, Nosjean O, Audinot V, Arrang JM, Buisson B, Steidl E, Delbos JM, Huhtala T, Kontkanen O, Chollet AM, Casara P, Lestage P.
    Eur J Pharmacol; 2017 May 15; 803():11-23. PubMed ID: 28336400
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA.
    Biochem Pharmacol; 2004 Sep 01; 68(5):933-45. PubMed ID: 15294456
    [Abstract] [Full Text] [Related]

  • 14. High constitutive activity of native H3 receptors regulates histamine neurons in brain.
    Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM.
    Nature; 2000 Dec 14; 408(6814):860-4. PubMed ID: 11130725
    [Abstract] [Full Text] [Related]

  • 15. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
    Célanire S, Wijtmans M, Christophe B, Collart P, de Esch I, Dassesse D, Delaunoy C, Denonne F, Durieu V, Gelens E, Gillard M, Lallemand B, Lamberty Y, Lebon F, Nicolas JM, Quéré L, Snip E, Vanbellinghen A, Van Houtvin N, Verbois V, Timmerman H, Talaga P, Leurs R, Provins L.
    ChemMedChem; 2009 Jul 14; 4(7):1063-8. PubMed ID: 19405064
    [Abstract] [Full Text] [Related]

  • 16. Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activity.
    Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL.
    J Med Chem; 2012 Jan 12; 55(1):414-23. PubMed ID: 22107017
    [Abstract] [Full Text] [Related]

  • 17. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease.
    Motawaj M, Burban A, Davenas E, Arrang JM.
    J Pharmacol Exp Ther; 2011 Feb 12; 336(2):479-87. PubMed ID: 21057059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.